SEO URLwww.firestrike.ai/deals/neuronos-ltd-xtl-biopharmaceuticals-acquisition-2026
acquisitionAnnounced · Jan 13, 2026BiotechnologySource · CredibleArticle · Factual
XTL Biopharmaceuticals acquires NeuroNOS Ltd.
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$33.5M
Target
NeuroNOS Ltd.
NASDAQ: XAIR
Acquirer
XTL Biopharmaceuticals
Full Acquisition
Status
Announced
XTL Biopharmaceuticals agreed to acquire NeuroNOS Ltd.. Reported deal value: $33.5M. Status: Announced. Sector: Biotechnology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-13. Figures and status may change as filings and press coverage update.
XTL Biopharmaceuticals Ltd
Deal timeline
Announced
Jan 13, 2026 · globenewswire.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $33.5M. Figures and status may change as sources update.
Sources: globenewswire.com · Primary article · FireStrike proprietary index